TTS Ltd. and the
Wellcome Trust will be holding its 2013 edition of TTS Europe on July 1-2, 2013
at the Welcome Trust in London, UK.  The
TTS Global Initiative is the leading international meeting for biotech sector Industry-academia
licensing, partnering, and technology transfer. 
TTS Europe is not an IP Counsel meeting, but a multi-stakeholder meeting
where IP and early-stage biotech are front and center and where Tech Transfer
Officers and IP professionals discuss and debate issues, models, and strategy
directly with other key stakeholders in early-stage biotech and bio-pharma
innovation.

A full program for
TTS Europe, including an agenda of each event's sessions and list of speakers
can be obtained here.  Patent
Docs author Dr. Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff
LLP will provide a presentation on "The most important trends &
developments in global biotech IP, or what the hell is happening in the
US?"

The registration
fee for TTS Europe is £599
(academic Innovators, university or Institute Technology Transfer Officers,
non-governmental or non-profit organizations, and start-ups) or £999 (multinational, corporate, legal
& consulting, and government).  Patent Docs readers who register using
the Code CJS13 will be able to secure a reduced registration fee of £399 (academic Innovators, university
or Institute Technology Transfer Officers, non-governmental or non-profit
organizations, and start-ups) or £699
(multinational, corporate, legal & consulting, and government).  Details regarding registration for the event
can be found here.

Patent Docs and McDonnell Boehnen Hulbert & Berghoff LLP are partners of TTS
Europe.